4.7 Review

Strategies for designing proteolysis targeting chimaeras (PROTACs)

期刊

MEDICINAL RESEARCH REVIEWS
卷 42, 期 3, 页码 1280-1342

出版社

WILEY
DOI: 10.1002/med.21877

关键词

design strategy; drug-likeness; E3 ligase ligands; proteolysis targeting chimaeras; targeted protein degradation

资金

  1. Shanghai Rising-Star Program [20QA1411700]
  2. National Key Research and Development Program of China [2020YFA0509100]
  3. National Natural Science Foundation of China [82003567, 82030105]

向作者/读者索取更多资源

This review comprehensively summarizes state-of-the-art methods and strategies in the design of PROTACs, including design principles, case studies, and emerging types. It also discusses the advantages and limitations of these strategies.
Proteolysis targeting chimaeras (PROTACs) is a cutting edge and rapidly growing technique for new drug discovery and development. Currently, the largest challenge in the molecular design and drug development of PROTACs is efficient identification of potent and drug-like degraders. This review aims to comprehensively summarize and analyse state-of-the-art methods and strategies in the design of PROTACs. We provide a detailed illustration of the general principles and tactics for designing potent PROTACs, highlight representative case studies, and discuss the advantages and limitations of these strategies. Particularly, structure-based rational PROTAC design and emerging new types of PROTACs (e.g., homo-PROTACs, multitargeting PROTACs, photo-control PROTACs and PROTAC-based conjugates) will be focused on.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据